Article info
PDFClinical and epidemiological research
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
- Ingiäld Hafström, Rheumatology Department, R92, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden; ingiald.hafstrom{at}karolinska.se
Citation
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
Publication history
- Accepted April 9, 2008
- First published April 17, 2008.
Online issue publication
March 13, 2009
Article Versions
- Previous version (17 April 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism